Sulfonamide Antibacterial [EPC]

Sulfonamide Antibacterial [EPC] was reported 3996 times

Drugs of the Sulfonamide Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PRIDE SYNDROME 6 0.3158
1 PULMONARY VASCULITIS 117 0.2175
2 TOTAL LUNG CAPACITY ABNORMAL 83 0.2134
3 CAPILLARITIS 48 0.1739
4 BALAMUTHIA INFECTION 4 0.1379
5 CONGENITAL TOXOPLASMOSIS 7 0.1296
6 SPIROMETRY ABNORMAL 77 0.1288
7 MITE ALLERGY 81 0.1237
8 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 7 0.1167
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 83 0.1132
10 MYCOTIC ALLERGY 80 0.0936
11 INFECTION PROTOZOAL 5 0.0877
12 DUST ALLERGY 81 0.0826
13 NEURITIS 119 0.0770
14 SKIN GRAFT FAILURE 8 0.0755
15 CONJUNCTIVITIS ALLERGIC 81 0.0547
16 CEREBRAL TOXOPLASMOSIS 49 0.0525
17 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 103 0.0505
18 RESPIRATORY SYMPTOM 113 0.0397
19 ACANTHAMOEBA INFECTION 7 0.0372
20 CENTRAL PAIN SYNDROME 9 0.0340
21 FORCED EXPIRATORY VOLUME DECREASED 85 0.0300
22 NORMOCHROMIC NORMOCYTIC ANAEMIA 84 0.0279
23 AUTOINFLAMMATORY DISEASE 5 0.0236
24 EYE INFECTION TOXOPLASMAL 9 0.0227
25 TOXOPLASMOSIS 24 0.0222
26 PULMONARY ALVEOLAR HAEMORRHAGE 120 0.0214
27 NEUROLOGICAL SYMPTOM 122 0.0213
28 DYSPLASTIC NAEVUS 6 0.0166
29 CLOSTRIDIAL SEPSIS 4 0.0165
30 ARTERIOSCLEROSIS CORONARY ARTERY 92 0.0139
31 CRYSTALLURIA 7 0.0129
32 SJS-TEN OVERLAP 9 0.0128
33 LENTIGO 6 0.0121
34 NEONATAL RESPIRATORY DEPRESSION 4 0.0120
35 PHOTODERMATOSIS 5 0.0118
36 DEAFNESS TRANSITORY 10 0.0117
37 OBSTRUCTIVE AIRWAYS DISORDER 119 0.0107
38 ELECTRIC SHOCK 9 0.0105
39 FULL BLOOD COUNT ABNORMAL 108 0.0102
40 VASCULITIS 117 0.0100
41 KAPOSI'S SARCOMA 5 0.0100
42 ARTERIOSCLEROSIS 90 0.0096
43 ALLODYNIA 11 0.0094
44 WOUND DRAINAGE 7 0.0088
45 BURNS THIRD DEGREE 9 0.0085
46 ORAL CAVITY FISTULA 4 0.0082
47 OEDEMA GENITAL 5 0.0078
48 HYPERPARATHYROIDISM SECONDARY 19 0.0076
49 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 6 0.0073
50 ASTIGMATISM 11 0.0073
51 NODULE 91 0.0070
52 LIPASE INCREASED 53 0.0069
53 PLEOCYTOSIS 4 0.0069
54 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 114 0.0067
55 BRONCHIAL HYPERREACTIVITY 8 0.0067
56 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 4 0.0065
57 PULMONARY FIBROSIS 123 0.0064
58 GLOMERULOSCLEROSIS 4 0.0063
59 INFECTION REACTIVATION 7 0.0061
60 GINGIVAL DISCOMFORT 4 0.0061
61 CATARACT NUCLEAR 4 0.0060
62 INTRACRANIAL MASS 5 0.0053
63 REBOUND ACID HYPERSECRETION 16 0.0053
64 RETINITIS 9 0.0052
65 LUMBAR RADICULOPATHY 6 0.0052
66 NEPHROGENIC ANAEMIA 24 0.0052
67 ABDOMINAL SYMPTOM 4 0.0050
68 HYPOGONADISM 5 0.0049
69 CORONAVIRUS TEST POSITIVE 5 0.0049
70 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
71 HAEMOPTYSIS 131 0.0047
72 ADENOCARCINOMA PANCREAS 6 0.0047
73 CYTOMEGALOVIRUS CHORIORETINITIS 9 0.0046
74 BLOOD PRESSURE SYSTOLIC ABNORMAL 11 0.0044
75 PRIMARY SEQUESTRUM 4 0.0044
76 NASAL ULCER 7 0.0044
77 CD4 LYMPHOCYTES DECREASED 9 0.0042
78 COR PULMONALE 4 0.0042
79 TOXIC EPIDERMAL NECROLYSIS 63 0.0041
80 WOUND COMPLICATION 14 0.0041
81 HYPOTHYROIDISM 129 0.0040
82 THERMAL BURN 28 0.0039
83 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
84 LEFT ATRIAL DILATATION 5 0.0039
85 DYSAESTHESIA 12 0.0039
86 PORTAL HYPERTENSION 12 0.0039
87 METHAEMOGLOBINAEMIA 9 0.0039
88 BONE DEMINERALISATION 4 0.0038
89 PRODUCT NAME CONFUSION 4 0.0037
90 CENTRAL NERVOUS SYSTEM LYMPHOMA 5 0.0036
91 PSEUDOMEMBRANOUS COLITIS 8 0.0036
92 KLEBSIELLA SEPSIS 4 0.0035
93 WOUND INFECTION STAPHYLOCOCCAL 6 0.0035
94 RADIATION SKIN INJURY 4 0.0034
95 END STAGE RENAL DISEASE 62 0.0034
96 BONE MARROW TOXICITY 4 0.0034
97 FRACTURED SACRUM 4 0.0032
98 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
99 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0031
100 POLYDIPSIA 12 0.0030
101 CYTOLYTIC HEPATITIS 10 0.0030
102 CARBON DIOXIDE INCREASED 4 0.0029
103 FUNCTIONAL GASTROINTESTINAL DISORDER 10 0.0029
104 HYPOXIA 100 0.0028
105 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
106 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
107 SEBORRHOEIC KERATOSIS 4 0.0028
108 LUNG DISORDER 134 0.0027
109 ACTINIC KERATOSIS 7 0.0027
110 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
111 CALCULUS URINARY 4 0.0026
112 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
113 ULCERATIVE KERATITIS 7 0.0026
114 MEGACOLON 4 0.0025
115 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4 0.0025
116 MITRAL VALVE PROLAPSE 4 0.0024
117 PURPURA 21 0.0024
118 EXCORIATION 6 0.0024
119 FEMALE GENITAL TRACT FISTULA 4 0.0023
120 DECUBITUS ULCER 19 0.0023
121 SKIN ABRASION 11 0.0023
122 HYPOPITUITARISM 4 0.0023
123 BURNS SECOND DEGREE 4 0.0023
124 FANCONI SYNDROME ACQUIRED 4 0.0023
125 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109 0.0023
126 RHINITIS ALLERGIC 10 0.0022
127 SKIN ULCER 58 0.0022
128 BLOOD PHOSPHORUS INCREASED 6 0.0022
129 CHRONIC KIDNEY DISEASE 166 0.0022
130 CALCIPHYLAXIS 4 0.0022
131 NEUROLOGICAL DECOMPENSATION 5 0.0022
132 WHEEZING 128 0.0022
133 PRODUCTIVE COUGH 103 0.0022
134 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 5 0.0021
135 PERIPHERAL VASCULAR DISORDER 11 0.0021
136 INFECTED SKIN ULCER 4 0.0021
137 DIABETES INSIPIDUS 5 0.0021
138 AZOTAEMIA 8 0.0020
139 SYSTEMIC CANDIDA 5 0.0020
140 NECROSIS 11 0.0020
141 APPLICATION SITE DISCOLOURATION 8 0.0020
142 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 8 0.0020
143 ISCHAEMIC CARDIOMYOPATHY 6 0.0020
144 RENAL FAILURE CHRONIC 15 0.0019
145 FACIAL PAIN 17 0.0019
146 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 134 0.0019
147 ENTEROCOCCAL INFECTION 9 0.0019
148 HEPATIC NECROSIS 7 0.0019
149 SNORING 7 0.0018
150 POSTURE ABNORMAL 6 0.0018
151 GANGRENE 11 0.0018
152 DIABETIC NEUROPATHY 9 0.0018
153 MACULE 5 0.0018
154 ABNORMAL LOSS OF WEIGHT 12 0.0018
155 IMMUNE THROMBOCYTOPENIA 8 0.0017
156 VARICOSE VEIN 9 0.0017
157 SKIN NECROSIS 9 0.0017
158 CELLULITIS 86 0.0017
159 NECROTISING FASCIITIS 6 0.0017
160 INGROWING NAIL 4 0.0017
161 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
162 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
163 HEMIPLEGIA 14 0.0017
164 METABOLIC ENCEPHALOPATHY 5 0.0017
165 RADIUS FRACTURE 4 0.0017
166 BONE LESION 6 0.0017
167 ECONOMIC PROBLEM 25 0.0016
168 AORTIC VALVE INCOMPETENCE 7 0.0016
169 PURULENT DISCHARGE 7 0.0016
170 PANCYTOPENIA 90 0.0016
171 MALNUTRITION 18 0.0016
172 NEPHROPATHY 15 0.0016
173 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
174 CHRONIC SINUSITIS 6 0.0016
175 ENCEPHALITIS 11 0.0016
176 OSTEITIS 4 0.0016
177 KLEBSIELLA INFECTION 8 0.0016
178 STEVENS-JOHNSON SYNDROME 34 0.0015
179 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
180 SQUAMOUS CELL CARCINOMA OF SKIN 9 0.0015
181 PNEUMONIA ASPIRATION 37 0.0015
182 CLOSTRIDIAL INFECTION 5 0.0015
183 RENAL TUBULAR NECROSIS 14 0.0014
184 BONE MARROW FAILURE 29 0.0014
185 HYPERLIPIDAEMIA 17 0.0014
186 HYPOALBUMINAEMIA 11 0.0014
187 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
188 SKIN WEEPING 5 0.0014
189 PYODERMA GANGRENOSUM 5 0.0014
190 MELANOCYTIC NAEVUS 6 0.0014
191 BLOOD PHOSPHORUS DECREASED 5 0.0014
192 ORAL CANDIDIASIS 18 0.0014
193 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
194 SKIN LESION 37 0.0013
195 FAILURE TO THRIVE 7 0.0013
196 ATELECTASIS 13 0.0013
197 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
198 PROTEIN TOTAL DECREASED 5 0.0013
199 NEPHROGENIC SYSTEMIC FIBROSIS 4 0.0013
200 ECCHYMOSIS 9 0.0013
201 MASTICATION DISORDER 4 0.0013
202 OVERWEIGHT 7 0.0013
203 OESOPHAGEAL ULCER 5 0.0013
204 SYNOVIAL CYST 6 0.0013
205 ANHEDONIA 34 0.0013
206 CARDIOMYOPATHY 19 0.0013
207 PULMONARY EMBOLISM 122 0.0013
208 PSEUDOMONAS INFECTION 11 0.0013
209 PRE-EXISTING CONDITION IMPROVED 8 0.0013
210 PAPULE 9 0.0013
211 WOUND SECRETION 5 0.0013
212 CARDIAC MURMUR 11 0.0013
213 RASH MACULO-PAPULAR 28 0.0013
214 ORTHOPNOEA 4 0.0013
215 CANDIDIASIS 5 0.0012
216 PROCTALGIA 8 0.0012
217 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
218 PERIPHERAL ISCHAEMIA 5 0.0012
219 POLYURIA 10 0.0012
220 STAPHYLOCOCCAL SEPSIS 6 0.0012
221 LEG AMPUTATION 5 0.0012
222 PHARYNGITIS 15 0.0012
223 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0012
224 HIDRADENITIS 11 0.0012
225 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
226 HYPERNATRAEMIA 6 0.0012
227 ANXIETY DISORDER 4 0.0012
228 HYPOVOLAEMIA 7 0.0012
229 ASTHMA 135 0.0012
230 THROMBOSIS 95 0.0012
231 PHLEBITIS 6 0.0012
232 SKIN INFECTION 13 0.0012
233 PANCREATITIS 61 0.0012
234 AORTIC STENOSIS 4 0.0011
235 RENAL FAILURE 152 0.0011
236 MUSCLE SPASTICITY 14 0.0011
237 SPINAL OSTEOARTHRITIS 10 0.0011
238 HYPOPHAGIA 29 0.0011
239 PHYSICAL DISABILITY 5 0.0011
240 ACUTE KIDNEY INJURY 172 0.0011
241 RHINITIS 9 0.0011
242 BLISTER 62 0.0011
243 MONOCYTE COUNT INCREASED 4 0.0011
244 SCLERODERMA 4 0.0011
245 SKIN DISCOLOURATION 50 0.0011
246 PARADOXICAL DRUG REACTION 4 0.0011
247 HERPES SIMPLEX 7 0.0011
248 RETINOPATHY 4 0.0011
249 STAPHYLOCOCCAL INFECTION 35 0.0011
250 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 58 0.0011
251 FACE INJURY 4 0.0011
252 SCAB 12 0.0011
253 FAECAL INCONTINENCE 5 0.0010
254 EATING DISORDER 22 0.0010
255 BREATH SOUNDS ABNORMAL 5 0.0010
256 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
257 BLOOD ALBUMIN DECREASED 8 0.0010
258 OESOPHAGEAL CANDIDIASIS 4 0.0010
259 PROTHROMBIN TIME PROLONGED 6 0.0010
260 GASTROINTESTINAL PAIN 11 0.0010
261 MUSCULOSKELETAL DISORDER 19 0.0010
262 RENAL FAILURE ACUTE 42 0.0010
263 ADRENAL INSUFFICIENCY 12 0.0010
264 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
265 TOOTH LOSS 20 0.0010
266 RASH PUSTULAR 7 0.0010
267 COAGULOPATHY 16 0.0010
268 FLANK PAIN 9 0.0010
269 APLASTIC ANAEMIA 5 0.0010
270 APPLICATION SITE PAIN 21 0.0010
271 MUSCLE ATROPHY 12 0.0009
272 RENAL INJURY 28 0.0009
273 POOR PERIPHERAL CIRCULATION 4 0.0009
274 ABSCESS LIMB 4 0.0009
275 MENTAL STATUS CHANGES 26 0.0009
276 ANAL FISSURE 5 0.0009
277 GASTROOESOPHAGEAL REFLUX DISEASE 75 0.0009
278 BLOOD MAGNESIUM DECREASED 8 0.0009
279 APPLICATION SITE VESICLES 6 0.0009
280 HEPATITIS ACUTE 6 0.0009
281 OSTEOPENIA 14 0.0009
282 DIVERTICULUM INTESTINAL 4 0.0009
283 PARONYCHIA 4 0.0009
284 SLEEP APNOEA SYNDROME 17 0.0009
285 LEUKOCYTOSIS 16 0.0009
286 ACUTE RESPIRATORY FAILURE 17 0.0009
287 OSTEOMYELITIS 16 0.0009
288 MITRAL VALVE INCOMPETENCE 10 0.0009
289 IMPAIRED HEALING 29 0.0009
290 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 6 0.0009
291 RENAL CYST 7 0.0009
292 PATHOGEN RESISTANCE 8 0.0009
293 ABDOMINAL HERNIA 4 0.0009
294 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
295 CARDIAC VALVE DISEASE 5 0.0009
296 INJECTION SITE PAPULE 4 0.0009
297 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
298 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
299 LYMPHOEDEMA 6 0.0009
300 MULTI-ORGAN FAILURE 15 0.0009
301 VENTRICULAR EXTRASYSTOLES 9 0.0009
302 PULMONARY HYPERTENSION 18 0.0009
303 AUTOIMMUNE HEPATITIS 6 0.0009
304 WOUND 24 0.0009
305 EOSINOPHILIA 15 0.0009
306 SPINAL PAIN 10 0.0009
307 APPLICATION SITE REACTION 6 0.0009
308 INCONTINENCE 9 0.0009
309 LACERATION 8 0.0008
310 URINE ODOUR ABNORMAL 5 0.0008
311 SQUAMOUS CELL CARCINOMA 8 0.0008
312 HIATUS HERNIA 11 0.0008
313 LYMPHADENOPATHY 30 0.0008
314 SKIN EXFOLIATION 71 0.0008
315 ODYNOPHAGIA 5 0.0008
316 HUMERUS FRACTURE 4 0.0008
317 CANDIDA INFECTION 14 0.0008
318 FAECES SOFT 6 0.0008
319 BURSITIS 10 0.0008
320 NEURALGIA 20 0.0008
321 FOETAL GROWTH RESTRICTION 5 0.0008
322 WOUND INFECTION 9 0.0008
323 COMA 39 0.0008
324 ABSCESS 13 0.0008
325 APPLICATION SITE BURN 4 0.0008
326 PANCREATIC DISORDER 4 0.0008
327 PIGMENTATION DISORDER 5 0.0008
328 MUSCLE STRAIN 7 0.0008
329 FOOT OPERATION 4 0.0008
330 ABDOMINAL TENDERNESS 4 0.0008
331 SUNBURN 6 0.0008
332 ANXIETY 229 0.0008
333 PROTEIN URINE PRESENT 4 0.0008
334 PEMPHIGOID 6 0.0008
335 SLEEP DISORDER 56 0.0008
336 FEEDING DISORDER 16 0.0008
337 DYSLIPIDAEMIA 4 0.0008
338 PRODUCT PRESCRIBING ISSUE 17 0.0008
339 PRODUCT COLOUR ISSUE 4 0.0008
340 RIB FRACTURE 16 0.0008
341 LYMPHOPENIA 11 0.0008
342 BLOOD UREA INCREASED 13 0.0008
343 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
344 CONDITION AGGRAVATED 234 0.0008
345 PETECHIAE 8 0.0008
346 NEPHROLITHIASIS 35 0.0008
347 LEUKOPENIA 38 0.0008
348 TOOTH INFECTION 10 0.0008
349 GRAND MAL CONVULSION 7 0.0008
350 FURUNCLE 6 0.0008
351 CONJUNCTIVITIS 14 0.0008
352 ADVERSE REACTION 10 0.0008
353 GINGIVAL PAIN 6 0.0008
354 COMPRESSION FRACTURE 4 0.0007
355 ANAL ABSCESS 4 0.0007
356 LYMPHOCYTE COUNT DECREASED 13 0.0007
357 PRODUCT USE IN UNAPPROVED INDICATION 182 0.0007
358 HYDROCEPHALUS 4 0.0007
359 DRUG TOXICITY 10 0.0007
360 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
361 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
362 PAIN IN EXTREMITY 212 0.0007
363 PHARYNGEAL SWELLING 7 0.0007
364 DEVICE RELATED INFECTION 11 0.0007
365 BONE DISORDER 13 0.0007
366 NEPHROPATHY TOXIC 8 0.0007
367 EXERCISE TOLERANCE DECREASED 4 0.0007
368 TOXIC SKIN ERUPTION 7 0.0007
369 DERMATITIS BULLOUS 5 0.0007
370 RALES 4 0.0007
371 GROIN PAIN 6 0.0007
372 ASCITES 20 0.0007
373 TENDERNESS 7 0.0007
374 BONE DENSITY DECREASED 21 0.0007
375 PHOTOSENSITIVITY REACTION 11 0.0007
376 JOINT DISLOCATION 7 0.0007
377 PLATELET COUNT ABNORMAL 4 0.0007
378 NO THERAPEUTIC RESPONSE 8 0.0007
379 HAEMATOCRIT DECREASED 13 0.0007
380 ENCEPHALOPATHY 16 0.0007
381 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
382 UROSEPSIS 6 0.0006
383 DEAFNESS 17 0.0006
384 DECREASED ACTIVITY 7 0.0006
385 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
386 HYPERCALCAEMIA 8 0.0006
387 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
388 OLIGURIA 4 0.0006
389 BIPOLAR DISORDER 7 0.0006
390 BACTERIAL INFECTION 12 0.0006
391 THERAPY PARTIAL RESPONDER 10 0.0006
392 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
393 MULTIPLE ALLERGIES 5 0.0006
394 TORSADE DE POINTES 5 0.0006
395 OSTEOARTHRITIS 27 0.0006
396 MULTIPLE INJURIES 4 0.0006
397 HEPATOCELLULAR INJURY 9 0.0006
398 BRAIN OEDEMA 8 0.0006
399 DENTAL CARIES 7 0.0006
400 PROTEINURIA 12 0.0006
401 TRICUSPID VALVE INCOMPETENCE 5 0.0006
402 HEPATIC CYTOLYSIS 8 0.0006
403 LIMB INJURY 17 0.0006
404 CHOLESTASIS 12 0.0006
405 HYPONATRAEMIA 35 0.0006
406 SINUS BRADYCARDIA 6 0.0006
407 LOCALISED INFECTION 15 0.0006
408 HEPATOMEGALY 6 0.0006
409 ACUTE MYOCARDIAL INFARCTION 18 0.0006
410 OEDEMA 33 0.0006
411 IMPAIRED WORK ABILITY 13 0.0006
412 ESCHERICHIA INFECTION 5 0.0006
413 TOOTHACHE 11 0.0006
414 HOSPICE CARE 6 0.0006
415 RASH ERYTHEMATOUS 29 0.0006
416 CORONAVIRUS INFECTION 4 0.0006
417 CARDIAC FAILURE ACUTE 4 0.0006
418 BLOOD POTASSIUM DECREASED 18 0.0006
419 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
420 ATAXIA 7 0.0006
421 NEUTROPHIL COUNT INCREASED 6 0.0006
422 WRIST FRACTURE 7 0.0006
423 BLOOD PRESSURE FLUCTUATION 14 0.0006
424 MUSCULOSKELETAL CHEST PAIN 9 0.0006
425 SKELETAL INJURY 6 0.0006
426 JOINT EFFUSION 4 0.0006
427 RASH PAPULAR 13 0.0006
428 PSYCHOLOGICAL TRAUMA 5 0.0006
429 LARGE INTESTINE PERFORATION 4 0.0006
430 SCHIZOPHRENIA 7 0.0006
431 LIVER INJURY 14 0.0006
432 HYPERKALAEMIA 20 0.0006
433 SCRATCH 6 0.0006
434 ULCER 9 0.0006
435 SEPSIS 63 0.0006
436 HAND FRACTURE 4 0.0006
437 HAEMORRHOIDS 11 0.0006
438 EAR INFECTION 15 0.0006
439 RESPIRATORY RATE INCREASED 5 0.0006
440 DEHYDRATION 75 0.0006
441 SUBDURAL HAEMATOMA 8 0.0006
442 GOUT 10 0.0006
443 ANAL INCONTINENCE 5 0.0006
444 BACK DISORDER 9 0.0006
445 LUPUS-LIKE SYNDROME 5 0.0006
446 LIMB DISCOMFORT 17 0.0005
447 OESOPHAGITIS 6 0.0005
448 CARDIAC FAILURE CONGESTIVE 44 0.0005
449 ROTATOR CUFF SYNDROME 7 0.0005
450 PNEUMONIA BACTERIAL 5 0.0005
451 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
452 OEDEMA PERIPHERAL 66 0.0005
453 HYPOPHOSPHATAEMIA 4 0.0005
454 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
455 ARTHROPOD BITE 4 0.0005
456 SKIN DISORDER 18 0.0005
457 PULMONARY MASS 8 0.0005
458 IMMUNODEFICIENCY 8 0.0005
459 ERYTHEMA MULTIFORME 5 0.0005
460 RENAL IMPAIRMENT 45 0.0005
461 OSTEOPOROSIS 22 0.0005
462 HYDRONEPHROSIS 4 0.0005
463 BLOOD CALCIUM DECREASED 6 0.0005
464 EYE INFECTION 6 0.0005
465 HEMIPARESIS 9 0.0005
466 BLOOD SODIUM DECREASED 10 0.0005
467 ANAEMIA 101 0.0005
468 NEUTROPENIA 72 0.0005
469 SEPTIC SHOCK 23 0.0005
470 MYOCARDIAL ISCHAEMIA 6 0.0005
471 DERMATITIS CONTACT 6 0.0005
472 SCAR 9 0.0005
473 MICTURITION URGENCY 6 0.0005
474 HAEMODYNAMIC INSTABILITY 4 0.0005
475 DERMATITIS 11 0.0005
476 MALIGNANT MELANOMA 7 0.0005
477 HYPERCHOLESTEROLAEMIA 5 0.0005
478 HYPERSENSITIVITY 96 0.0005
479 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
480 RASH MACULAR 18 0.0005
481 PULMONARY OEDEMA 23 0.0005
482 IRRITABLE BOWEL SYNDROME 11 0.0005
483 DRUG ERUPTION 9 0.0005
484 LIGAMENT SPRAIN 5 0.0005
485 BLOOD CREATININE INCREASED 33 0.0005
486 SINUS DISORDER 10 0.0005
487 DYSPNOEA EXERTIONAL 19 0.0005
488 OBESITY 8 0.0005
489 THROMBOCYTOPENIA 56 0.0005
490 FEBRILE NEUTROPENIA 33 0.0005
491 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
492 CORONARY ARTERY DISEASE 15 0.0005
493 GASTRITIS 13 0.0005
494 HYPOTHERMIA 5 0.0005
495 EYELID PTOSIS 5 0.0005
496 DISCOMFORT 30 0.0005
497 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
498 CYTOPENIA 6 0.0005
499 DYSURIA 18 0.0005
500 CARDIOMEGALY 6 0.0005
501 HYPERAESTHESIA 4 0.0005
502 IMPAIRED QUALITY OF LIFE 7 0.0005
503 PARAESTHESIA ORAL 7 0.0005
504 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
505 POOR VENOUS ACCESS 5 0.0005
506 HAIR COLOUR CHANGES 6 0.0005
507 CYTOMEGALOVIRUS INFECTION 8 0.0005
508 DYSPNOEA 271 0.0005
509 HYPOKALAEMIA 22 0.0005
510 BURNING SENSATION 33 0.0005
511 BREAST PAIN 5 0.0005
512 POST PROCEDURAL COMPLICATION 9 0.0005
513 HAEMATURIA 16 0.0005
514 DRUG RESISTANCE 12 0.0005
515 RESPIRATORY FAILURE 34 0.0005
516 BONE LOSS 7 0.0005
517 SKIN CANCER 10 0.0005
518 RASH GENERALISED 12 0.0005
519 OXYGEN SATURATION DECREASED 26 0.0005
520 SKIN FISSURES 9 0.0005
521 SKIN LACERATION 5 0.0005
522 BACK INJURY 5 0.0005
523 KIDNEY INFECTION 9 0.0005
524 BEDRIDDEN 6 0.0005
525 PULMONARY CONGESTION 6 0.0005
526 RED BLOOD CELL COUNT DECREASED 13 0.0005
527 IMMUNOSUPPRESSION 4 0.0005
528 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
529 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
530 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
531 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
532 LIP SWELLING 15 0.0004
533 NERVE INJURY 5 0.0004
534 HAIR TEXTURE ABNORMAL 6 0.0004
535 NECK PAIN 25 0.0004
536 VOMITING 210 0.0004
537 ORAL PAIN 10 0.0004
538 DEEP VEIN THROMBOSIS 29 0.0004
539 EMOTIONAL DISTRESS 54 0.0004
540 HEAVY MENSTRUAL BLEEDING 4 0.0004
541 PLEURAL EFFUSION 27 0.0004
542 OROPHARYNGEAL DISCOMFORT 4 0.0004
543 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
544 PNEUMOTHORAX 7 0.0004
545 C-REACTIVE PROTEIN INCREASED 16 0.0004
546 URINARY TRACT INFECTION 75 0.0004
547 TACHYCARDIA 39 0.0004
548 URINARY INCONTINENCE 13 0.0004
549 EXOSTOSIS 4 0.0004
550 NIGHT SWEATS 14 0.0004
551 MUSCULOSKELETAL STIFFNESS 38 0.0004
552 IRON DEFICIENCY ANAEMIA 4 0.0004
553 BLOOD POTASSIUM INCREASED 7 0.0004
554 PERSONALITY CHANGE 4 0.0004
555 AGRANULOCYTOSIS 8 0.0004
556 ELECTROLYTE IMBALANCE 5 0.0004
557 DEFORMITY 4 0.0004
558 HEART RATE DECREASED 15 0.0004
559 INJURY 30 0.0004
560 MULTIPLE FRACTURES 7 0.0004
561 SINUS TACHYCARDIA 6 0.0004
562 RESPIRATORY TRACT INFECTION 11 0.0004
563 FOOT FRACTURE 8 0.0004
564 BACTERAEMIA 5 0.0004
565 PRODUCT PRESCRIBING ERROR 10 0.0004
566 BRONCHITIS 31 0.0004
567 ACCIDENT 5 0.0004
568 MACULAR DEGENERATION 5 0.0004
569 POLYNEUROPATHY 5 0.0004
570 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
571 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
572 PAIN 251 0.0004
573 INFUSION RELATED REACTION 27 0.0004
574 METABOLIC ACIDOSIS 13 0.0004
575 BODY TEMPERATURE DECREASED 4 0.0004
576 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
577 LIVER DISORDER 18 0.0004
578 ABASIA 10 0.0004
579 DECREASED APPETITE 94 0.0004
580 BACK PAIN 94 0.0004
581 DRUG INTOLERANCE 39 0.0004
582 DELIRIUM 14 0.0004
583 EYE SWELLING 15 0.0004
584 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
585 ILEUS 5 0.0004
586 HAEMORRHAGE INTRACRANIAL 6 0.0004
587 EPISTAXIS 30 0.0004
588 ATRIAL FIBRILLATION 39 0.0004
589 PANCREATITIS ACUTE 9 0.0004
590 INJECTION SITE DISCOLOURATION 5 0.0004
591 HAEMOGLOBIN DECREASED 41 0.0004
592 SPINAL FRACTURE 8 0.0004
593 SECRETION DISCHARGE 5 0.0004
594 PREMATURE BABY 12 0.0004
595 RESPIRATORY DISTRESS 11 0.0004
596 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
597 SWELLING 37 0.0004
598 SHOCK 9 0.0004
599 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
600 RASH 170 0.0004
601 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
602 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
603 ANKLE FRACTURE 6 0.0004
604 UNRESPONSIVE TO STIMULI 10 0.0004
605 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
606 RESTLESS LEGS SYNDROME 7 0.0004
607 ANGINA PECTORIS 11 0.0004
608 HERPES ZOSTER 22 0.0004
609 APPLICATION SITE ERYTHEMA 10 0.0004
610 CYANOSIS 6 0.0004
611 DISEASE PROGRESSION 45 0.0004
612 PNEUMONIA 123 0.0004
613 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
614 STOMATITIS 23 0.0004
615 LIVER FUNCTION TEST ABNORMAL 11 0.0004
616 ARTHROPATHY 21 0.0004
617 DYSSTASIA 11 0.0004
618 PERIPHERAL SWELLING 58 0.0004
619 JOINT INJURY 8 0.0004
620 BODY HEIGHT DECREASED 4 0.0004
621 SENSORY DISTURBANCE 6 0.0004
622 JOINT RANGE OF MOTION DECREASED 5 0.0004
623 PYREXIA 129 0.0004
624 SOMNOLENCE 75 0.0004
625 LACTIC ACIDOSIS 12 0.0004
626 BALANCE DISORDER 32 0.0004
627 HYPOCALCAEMIA 7 0.0004
628 PHARYNGITIS STREPTOCOCCAL 4 0.0004
629 PSORIATIC ARTHROPATHY 15 0.0004
630 HYPOTENSION 74 0.0004
631 DYSPHAGIA 35 0.0004
632 GASTROINTESTINAL DISORDER 33 0.0004
633 TACHYPNOEA 5 0.0004
634 METASTASES TO BONE 6 0.0004
635 TREATMENT NONCOMPLIANCE 20 0.0004
636 VENTRICULAR TACHYCARDIA 6 0.0004
637 MUSCULOSKELETAL PAIN 19 0.0004
638 DIVERTICULITIS 10 0.0004
639 VIRAL INFECTION 12 0.0004
640 FUNGAL INFECTION 12 0.0004
641 TRANSAMINASES INCREASED 8 0.0004
642 CHOKING 7 0.0004
643 CARPAL TUNNEL SYNDROME 5 0.0004
644 FACE OEDEMA 6 0.0004
645 WEIGHT DECREASED 99 0.0004
646 FALL 118 0.0004
647 DIABETES MELLITUS 27 0.0004
648 SEASONAL ALLERGY 5 0.0004
649 CHILLS 41 0.0003
650 CARDIOGENIC SHOCK 5 0.0003
651 NEOPLASM 4 0.0003
652 HAEMATOMA 9 0.0003
653 MADAROSIS 4 0.0003
654 CAESAREAN SECTION 4 0.0003
655 ARTHRITIS 27 0.0003
656 MUSCULAR WEAKNESS 39 0.0003
657 COLITIS 13 0.0003
658 HIP FRACTURE 11 0.0003
659 BONE PAIN 20 0.0003
660 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
661 SURGERY 20 0.0003
662 CONSTIPATION 74 0.0003
663 COVID-19 PNEUMONIA 4 0.0003
664 ARRHYTHMIA 16 0.0003
665 SKIN HAEMORRHAGE 5 0.0003
666 BLOOD IRON DECREASED 4 0.0003
667 CHOLECYSTITIS 4 0.0003
668 CONFUSIONAL STATE 54 0.0003
669 SINUSITIS 34 0.0003
670 HEPATIC FAILURE 10 0.0003
671 ASTHENIA 124 0.0003
672 NOCTURIA 4 0.0003
673 PRESYNCOPE 8 0.0003
674 OFF LABEL USE 288 0.0003
675 DRUG DISPENSING ERROR 5 0.0003
676 RECTAL HAEMORRHAGE 14 0.0003
677 EMOTIONAL DISORDER 10 0.0003
678 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
679 TENDONITIS 5 0.0003
680 FAECES DISCOLOURED 7 0.0003
681 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
682 RENAL DISORDER 15 0.0003
683 BLOOD CHOLESTEROL INCREASED 15 0.0003
684 APPLICATION SITE IRRITATION 4 0.0003
685 ACUTE MYELOID LEUKAEMIA 5 0.0003
686 HYPOAESTHESIA 48 0.0003
687 HEPATIC CIRRHOSIS 6 0.0003
688 NEUTROPHIL COUNT DECREASED 13 0.0003
689 DERMATITIS ALLERGIC 4 0.0003
690 RHEUMATOID ARTHRITIS 36 0.0003
691 ANGIOEDEMA 14 0.0003
692 UNDERDOSE 23 0.0003
693 CONVULSION 18 0.0003
694 HEPATOTOXICITY 7 0.0003
695 HYPERSOMNIA 9 0.0003
696 ABDOMINAL PAIN 73 0.0003
697 SCIATICA 5 0.0003
698 OROPHARYNGEAL PAIN 29 0.0003
699 PARAESTHESIA 49 0.0003
700 INFUSION SITE PAIN 4 0.0003
701 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
702 INJECTION SITE INDURATION 4 0.0003
703 NAUSEA 243 0.0003
704 NASAL CONGESTION 18 0.0003
705 MUSCLE TWITCHING 7 0.0003
706 DEPRESSION 69 0.0003
707 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
708 PERICARDIAL EFFUSION 7 0.0003
709 BLOOD PRESSURE ABNORMAL 6 0.0003
710 EYE HAEMORRHAGE 4 0.0003
711 GAIT INABILITY 10 0.0003
712 FLUID RETENTION 15 0.0003
713 BODY TEMPERATURE INCREASED 6 0.0003
714 PALLOR 8 0.0003
715 IMPAIRED GASTRIC EMPTYING 4 0.0003
716 ACUTE HEPATIC FAILURE 4 0.0003
717 DIABETIC KETOACIDOSIS 7 0.0003
718 ARTHRALGIA 121 0.0003
719 PLATELET COUNT DECREASED 31 0.0003
720 MUSCULOSKELETAL DISCOMFORT 5 0.0003
721 THROAT IRRITATION 13 0.0003
722 FIBROMYALGIA 7 0.0003
723 POLLAKIURIA 12 0.0003
724 FEELING COLD 8 0.0003
725 ORTHOSTATIC HYPOTENSION 5 0.0003
726 ERYTHEMA 59 0.0003
727 CARDIO-RESPIRATORY ARREST 12 0.0003
728 COORDINATION ABNORMAL 4 0.0003
729 LOCAL SWELLING 5 0.0003
730 HOSPITALISATION 44 0.0003
731 MOUTH ULCERATION 6 0.0003
732 DERMATITIS ATOPIC 15 0.0003
733 OSTEONECROSIS OF JAW 7 0.0003
734 PAIN IN JAW 8 0.0003
735 GAIT DISTURBANCE 54 0.0003
736 PLASMA CELL MYELOMA 11 0.0003
737 DIALYSIS 4 0.0003
738 AGEUSIA 7 0.0003
739 INTENTIONAL DOSE OMISSION 8 0.0003
740 ABDOMINAL DISCOMFORT 47 0.0003
741 LIVER FUNCTION TEST INCREASED 6 0.0003
742 RASH PRURITIC 15 0.0003
743 SWELLING FACE 18 0.0003
744 FLUID OVERLOAD 4 0.0003
745 CHOLELITHIASIS 9 0.0003
746 HYPERGLYCAEMIA 10 0.0003
747 GASTROENTERITIS 4 0.0003
748 OSTEONECROSIS 9 0.0003
749 HEPATITIS 7 0.0003
750 MALIGNANT NEOPLASM PROGRESSION 28 0.0003
751 RESTLESSNESS 10 0.0003
752 ERECTILE DYSFUNCTION 7 0.0003
753 MIGRAINE 26 0.0003
754 DIARRHOEA 175 0.0003
755 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
756 CONTUSION 26 0.0003
757 TOOTH DISORDER 6 0.0003
758 MATERNAL EXPOSURE DURING PREGNANCY 24 0.0003
759 CATARACT 16 0.0003
760 INTERSTITIAL LUNG DISEASE 13 0.0003
761 FATIGUE 209 0.0003
762 HEPATIC FUNCTION ABNORMAL 10 0.0003
763 MUCOSAL INFLAMMATION 7 0.0003
764 CHROMATURIA 6 0.0003
765 HEART RATE IRREGULAR 6 0.0003
766 JOINT SWELLING 32 0.0003
767 HYPERTENSION 56 0.0003
768 DYSPEPSIA 26 0.0003
769 GASTRIC ULCER 5 0.0003
770 DIZZINESS 131 0.0003
771 INFECTION 38 0.0003
772 INJECTION SITE REACTION 18 0.0003
773 INSURANCE ISSUE 4 0.0003
774 PRODUCT DOSE OMISSION 17 0.0003
775 LOWER LIMB FRACTURE 5 0.0003
776 PAIN OF SKIN 7 0.0003
777 SYNCOPE 26 0.0003
778 BLOOD BILIRUBIN INCREASED 7 0.0003
779 THROAT TIGHTNESS 7 0.0003
780 ERUCTATION 5 0.0003
781 ORAL HERPES 5 0.0003
782 SWOLLEN TONGUE 8 0.0003
783 MUSCLE SPASMS 47 0.0003
784 ADVERSE DRUG REACTION 23 0.0003
785 BLOOD PRESSURE DECREASED 17 0.0003
786 PRODUCT USE COMPLAINT 4 0.0003
787 DISABILITY 5 0.0003
788 PROCEDURAL PAIN 7 0.0003
789 INFLAMMATION 13 0.0003
790 HALLUCINATION, AUDITORY 4 0.0003
791 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
792 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
793 NASOPHARYNGITIS 46 0.0002
794 NERVOUSNESS 13 0.0002
795 BLOOD PRESSURE INCREASED 38 0.0002
796 ABDOMINAL PAIN UPPER 51 0.0002
797 CRYING 9 0.0002
798 HYPOGLYCAEMIA 12 0.0002
799 DRY SKIN 33 0.0002
800 MYALGIA 42 0.0002
801 DYSKINESIA 10 0.0002
802 COUGH 69 0.0002
803 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
804 ILLNESS 25 0.0002
805 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
806 PRURITUS 93 0.0002
807 NEUROPATHY PERIPHERAL 23 0.0002
808 TREMOR 40 0.0002
809 SKIN IRRITATION 11 0.0002
810 TINNITUS 11 0.0002
811 DYSPHONIA 14 0.0002
812 HALLUCINATION 18 0.0002
813 TYPE 2 DIABETES MELLITUS 8 0.0002
814 CHEST PAIN 44 0.0002
815 LABORATORY TEST ABNORMAL 7 0.0002
816 HALLUCINATION, VISUAL 5 0.0002
817 HAEMATEMESIS 6 0.0002
818 CARDIOVASCULAR DISORDER 6 0.0002
819 COGNITIVE DISORDER 11 0.0002
820 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
821 CIRCULATORY COLLAPSE 4 0.0002
822 HEADACHE 147 0.0002
823 GASTRIC DISORDER 8 0.0002
824 INSOMNIA 62 0.0002
825 MALAISE 102 0.0002
826 LACRIMATION INCREASED 7 0.0002
827 MENTAL DISORDER 10 0.0002
828 VERTIGO 14 0.0002
829 PRODUCT DISPENSING ERROR 5 0.0002
830 METASTASES TO LIVER 4 0.0002
831 DEATH 196 0.0002
832 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
833 LETHARGY 13 0.0002
834 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
835 VISION BLURRED 31 0.0002
836 MEMORY IMPAIRMENT 31 0.0002
837 INFLUENZA 25 0.0002
838 SKIN BURNING SENSATION 16 0.0002
839 DRUG-INDUCED LIVER INJURY 7 0.0002
840 MOBILITY DECREASED 16 0.0002
841 FREQUENT BOWEL MOVEMENTS 6 0.0002
842 HEAD INJURY 7 0.0002
843 URTICARIA 37 0.0002
844 APPLICATION SITE PRURITUS 5 0.0002
845 HAEMORRHAGE 23 0.0002
846 MOOD ALTERED 6 0.0002
847 CYSTITIS 7 0.0002
848 PRODUCT AVAILABILITY ISSUE 5 0.0002
849 AGITATION 16 0.0002
850 BLOOD GLUCOSE INCREASED 41 0.0002
851 BLOOD GLUCOSE ABNORMAL 4 0.0002
852 MEDICATION ERROR 12 0.0002
853 HEPATIC STEATOSIS 4 0.0002
854 EYE DISORDER 7 0.0002
855 TARDIVE DYSKINESIA 6 0.0002
856 PHOTOPHOBIA 4 0.0002
857 DYSARTHRIA 8 0.0002
858 HEART RATE INCREASED 21 0.0002
859 UNEVALUABLE EVENT 16 0.0002
860 BLOOD URINE PRESENT 4 0.0002
861 DRY MOUTH 17 0.0002
862 EXPOSURE DURING PREGNANCY 13 0.0002
863 EYE IRRITATION 12 0.0002
864 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
865 BLOOD GLUCOSE DECREASED 10 0.0002
866 GLAUCOMA 4 0.0002
867 PRESCRIBED OVERDOSE 4 0.0002
868 EAR PAIN 4 0.0002
869 CEREBRAL INFARCTION 5 0.0002
870 DISORIENTATION 8 0.0002
871 COLITIS ULCERATIVE 9 0.0002
872 RHINORRHOEA 13 0.0002
873 WEIGHT INCREASED 45 0.0002
874 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
875 RESPIRATORY DISORDER 6 0.0002
876 DRY EYE 10 0.0002
877 HAEMATOCHEZIA 11 0.0002
878 APHASIA 6 0.0002
879 FEELING HOT 12 0.0002
880 THERAPY CESSATION 10 0.0002
881 INJECTION SITE WARMTH 4 0.0002
882 CARDIAC ARREST 16 0.0002
883 TREATMENT FAILURE 16 0.0002
884 PANIC ATTACK 7 0.0002
885 RHABDOMYOLYSIS 8 0.0002
886 ABDOMINAL DISTENSION 20 0.0002
887 SEIZURE 22 0.0002
888 DRUG INTERACTION 30 0.0002
889 BRADYCARDIA 10 0.0002
890 ALOPECIA 37 0.0002
891 PALPITATIONS 22 0.0002
892 RETCHING 4 0.0002
893 LOSS OF CONSCIOUSNESS 24 0.0002
894 MOVEMENT DISORDER 6 0.0002
895 HYPOACUSIS 8 0.0002
896 JAUNDICE 5 0.0002
897 POOR QUALITY SLEEP 4 0.0002
898 VISUAL IMPAIRMENT 23 0.0002
899 DRUG INEFFECTIVE 240 0.0002
900 THERAPY INTERRUPTED 13 0.0002
901 THERAPEUTIC RESPONSE DECREASED 11 0.0002
902 VISUAL ACUITY REDUCED 6 0.0002
903 GLOSSODYNIA 4 0.0002
904 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
905 EYE PAIN 10 0.0002
906 PRODUCT DOSE OMISSION ISSUE 52 0.0002
907 COVID-19 31 0.0002
908 ABNORMAL BEHAVIOUR 7 0.0002
909 PSORIASIS 23 0.0002
910 CHEST DISCOMFORT 18 0.0002
911 SPEECH DISORDER 9 0.0002
912 AMNESIA 11 0.0002
913 DISEASE RECURRENCE 8 0.0002
914 ROAD TRAFFIC ACCIDENT 7 0.0002
915 MYOCARDIAL INFARCTION 29 0.0002
916 HYPERHIDROSIS 21 0.0002
917 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
918 CARDIAC FAILURE 13 0.0002
919 GYNAECOMASTIA 5 0.0002
920 DYSGEUSIA 12 0.0002
921 NERVOUS SYSTEM DISORDER 5 0.0002
922 THERAPY NON-RESPONDER 7 0.0002
923 JOINT STIFFNESS 4 0.0002
924 URINARY RETENTION 5 0.0001
925 EYE PRURITUS 5 0.0001
926 FEAR 4 0.0001
927 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
928 ANGER 5 0.0001
929 CEREBROVASCULAR ACCIDENT 25 0.0001
930 FLUSHING 15 0.0001
931 OCULAR HYPERAEMIA 7 0.0001
932 BLINDNESS 6 0.0001
933 MULTIPLE SCLEROSIS 7 0.0001
934 RESPIRATORY ARREST 4 0.0001
935 ABNORMAL DREAMS 4 0.0001
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
937 TOXICITY TO VARIOUS AGENTS 24 0.0001
938 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
939 PRODUCT QUALITY ISSUE 19 0.0001
940 CEREBRAL HAEMORRHAGE 5 0.0001
941 CARDIAC DISORDER 13 0.0001
942 MYELOSUPPRESSION 5 0.0001
943 ACCIDENTAL OVERDOSE 5 0.0001
944 HEPATIC ENZYME INCREASED 9 0.0001
945 ILL-DEFINED DISORDER 8 0.0001
946 SUICIDAL IDEATION 12 0.0001
947 INJECTION SITE SWELLING 10 0.0001
948 FEMUR FRACTURE 4 0.0001
949 DEVICE MALFUNCTION 9 0.0001
950 MOOD SWINGS 4 0.0001
951 FLATULENCE 7 0.0001
952 EXPIRED PRODUCT ADMINISTERED 4 0.0001
953 HOT FLUSH 9 0.0001
954 BREAST CANCER 11 0.0001
955 IRRITABILITY 7 0.0001
956 NIGHTMARE 4 0.0001
957 VAGINAL HAEMORRHAGE 5 0.0001
958 DEPRESSED MOOD 6 0.0001
959 DRUG EFFECT INCOMPLETE 4 0.0001
960 ANAPHYLACTIC REACTION 6 0.0001
961 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
962 NEOPLASM MALIGNANT 7 0.0001
963 INJECTION SITE PRURITUS 7 0.0001
964 FEELING ABNORMAL 25 0.0001
965 INTENTIONAL PRODUCT MISUSE 9 0.0001
966 PRODUCT USE ISSUE 19 0.0001
967 INJECTION SITE PAIN 31 0.0001
968 INJECTION SITE HAEMORRHAGE 8 0.0001
969 AGGRESSION 5 0.0001
970 ABORTION SPONTANEOUS 4 0.0001
971 EXTRA DOSE ADMINISTERED 4 0.0001
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
974 INFLUENZA LIKE ILLNESS 8 0.0001
975 DRUG EFFECT DECREASED 5 0.0001
976 ACNE 7 0.0001
977 INJECTION SITE BRUISING 7 0.0001
978 OVERDOSE 18 0.0001
979 NO ADVERSE EVENT 15 0.0001
980 DEVICE ISSUE 7 0.0001
981 ADVERSE EVENT 7 0.0001
982 DISTURBANCE IN ATTENTION 4 0.0001
983 DRUG DOSE OMISSION 12 0.0001
984 INJECTION SITE ERYTHEMA 9 0.0001
985 PRODUCT SUBSTITUTION ISSUE 4 0.0001
986 DRUG WITHDRAWAL SYNDROME 6 0.0001
987 BLADDER CANCER 4 0.0001
988 INCORRECT DOSE ADMINISTERED 15 0.0001
989 DRUG DEPENDENCE 10 0.0001
990 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
991 PROSTATE CANCER 4 0.0000
992 DRUG ABUSE 4 0.0000
993 PRODUCT STORAGE ERROR 4 0.0000